Solventum Corp
Solventum Corp is a U.S.-based healthcare company that develops, manufactures, and commercializes products used across prevention, diagnosis, treatment, and recovery. Its portfolio spans medical devices, dental solutions, health information systems, and purification and filtration technologies, with customers served in the United States and international markets.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueMedical and surgical products used in hospitals and other care settings.
Products and technologies used by dental professionals and clinics.
Software and digital workflow tools for healthcare documentation and data use.
Filtration and purification products for healthcare and industrial applications.
Products
Reported · share of revenue- Products76.3 %
- Cost of Software and Rentals23.7 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Solventum sells primarily to healthcare providers and related institutions that need regulated products, clinical workflow tools, and specialized materials. Its customer base includes multidisciplinary hospitals, local clinics and practices, and other healthcare organizations that buy to improve care quality, safety, efficiency, and compliance.
Buy MedSurg products and HIS tools to support clinical care, workflow, and patient safety.
Buy dental materials and equipment used in routine and specialized dental care.
Buy healthcare products and systems for day-to-day treatment and documentation needs.
Buy purification and filtration products for controlled-process applications.
Strategy
Solventum’s strategy centers on building a standalone healthcare platform around its core product families, while investing in manufacturing, sourcing, and digital capabilities. It also emphasizes innovation, regulatory compliance, and customer relationships to support adoption across hospitals, clinics, and other healthcare settings.
A separate corporate structure requires independent systems, brand building, and operating discipline.
Healthcare products depend on reliable supply, qualified components, and compliant facilities.
Differentiated products and digital tools support customer retention and market access.
Medical and pharmaceutical products require approvals, inspections, and ongoing compliance.
Geography
2025Solventum operates globally, with sales split between the United States and international markets. In 2025, the United States accounted for 56.1% of net sales and International for 43.9%, showing a broadly balanced geographic footprint with meaningful exposure to both domestic and non-U.S. healthcare markets.
Share of the revenue the company reports by geography.
Risks
Solventum faces regulatory, quality, supply chain, and cybersecurity risks typical of a regulated healthcare manufacturer. Its business is also exposed to pricing pressure, customer consolidation, and international trade or geopolitical disruptions, all of which can affect demand, market access, and operating execution.
- Regulatory approval and compliance riskImpact: HighLikelihood: Medium
Products are subject to FDA and non-U.S. medical device and pharmaceutical rules.
Exposure: Global product portfolio
- Product quality and recall riskImpact: HighLikelihood: Medium
Defects or improper use can trigger recalls, safety alerts, and lost sales.
Exposure: MedSurg and other regulated products
- Supply chain and sole-source supplier riskImpact: HighLikelihood: Medium
Interrupted supply or component shortages can prevent timely customer delivery.
Exposure: Manufacturing and sourced components
- Geopolitical and trade riskImpact: MediumLikelihood: High
International operations face tariffs, local policy shifts, and cross-border disruption.
Exposure: International markets
- Cybersecurity and IT riskImpact: MediumLikelihood: Medium
Healthcare data and proprietary systems are attractive targets and operationally sensitive.
Exposure: Health Information Systems and corporate systems
- Pricing pressure and customer consolidationImpact: MediumLikelihood: Medium
Large healthcare buyers can negotiate harder and exclude suppliers.
Exposure
Accounting
Judgemental itemsManagement must estimate fair value and future cash generation for reporting units.
Impact: Could create non-cash charges if assumptions weaken
Product, compliance, and commercial disputes require probability-based accruals.
Impact: Affects operating expenses and liabilities
The company established its own hedging program and has international exposure.
Impact: Can affect earnings volatility and OCI
Historical periods include allocations and methodologies from the former parent structure.
Impact: Limits comparability across periods
Similar listed companies
Publicly listed companies with a comparable business focus.
Scienture Holdings, Inc.
SCNX · Pharmaceutical Preparations
Revvity, Inc
RVTY · Laboratory Analytical Instruments
Revvity is a U.S.-based health science company that develops instruments, software, reagents, and services used across research, screening, diagnostics, and reproductive health workflows.
Rezolute, Inc.
RZLT · Pharmaceutical Preparations
Medline Inc.
MDLN · Surgical & Medical Instruments & Apparatus
Doximity, Inc.
DOCS · Services-Computer Programming Services
Doximity is a digital platform for U.S.
QuidelOrtho Corp
QDEL · In Vitro & In Vivo Diagnostic Substances
QuidelOrtho Corp develops and markets diagnostic testing products used to detect, monitor, and help manage disease across clinical and decentralized care settings.
Last updated: 24/09/2026